Mounjaro 15mg

Mounjaro 15 mg is the highest available strength of the once-weekly injectable medication tirzepatide, used for managing type 2 diabetes and promoting weight loss. It works by activating two hormones—GIP and GLP-1 receptors—to improve insulin response, lower blood sugar, slow digestion, and reduce appetite.

Key Features:

• Strength: 15 mg/0.5 mL in a single-use prefilled pen

• Use: Injected once weekly under the skin (abdomen, thigh, or upper arm)

• Typically prescribed: After titrating up from lower doses (e.g. 2.5 mg → 5 mg → 10 mg → 12.5 mg)

• Main benefits:

  • Significant reduction in blood glucose (HbA1c)

  • Enhanced weight loss

  • Appetite suppression

Common Side Effects:

• Nausea, vomiting, diarrhea, constipation, fatigue

• Possible injection site reactions

Storage:

• Keep refrigerated (2°C–8°C), or at room temperature (≤30°C) for up to 21 days

The 15 mg dose is often used when maximum therapeutic benefit is needed and lower doses are well tolerated. Always follow medical advice when adjusting to this dose.